書誌事項
- タイトル別名
-
- Studies on clinical significance of serum CA19-9 in patients with cholelithiasis.
この論文をさがす
抄録
Serum CA19-9 levels were measured using radioimmunoassay in 45 patients with cholelithiasis and clinical significance of serum CA19-9 was discussed. Results obtained were as follows:<br>1) Positive rate over cut off level of CA19-9 (>37U/ml) was 27.6% in patients with cholecystolithiasis and 68.8% with choledocholithiasis.<br>2) Positive rate of serum CA19-9 was high in patients with clinical symptoms such as cholecystitis, cholangitis and obstructive jaundice. The highest titer of CA19-9 was 2350U/ml in a patient with obstructive jaundice.<br>3) High titer of serum CA19-9 was improved in patients with cholecystolithiasis after subsidence of cholecystitis.<br>4) There was positive correlation between serum total bilirubin and serum CA19-9 in patients with choledocholithiasis. High titer of serum CA19-9 was normalized in all cases after improvement of obstructive jaundice.<br>It is suggested by these results that CA19-9 is secreted into bile and this antigen flows back into blood in situation of cholecystitis or obstruction of bile duct.
収録刊行物
-
- 日本消化器病学会雑誌
-
日本消化器病学会雑誌 83 (10), 2196-2200, 1986
一般財団法人 日本消化器病学会
- Tweet
詳細情報
-
- CRID
- 1390282681372084608
-
- NII論文ID
- 130001064815
- 80003125182
-
- COI
- 1:STN:280:DyaL2s7kt1Sqsw%3D%3D
-
- ISSN
- 13497693
- 04466586
-
- PubMed
- 3469449
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可